Response Genetics appoints Edith Mitchell to board
This article was originally published in Clinica
Executive Summary
Edith Mitchell has joined Response Genetics’ board of directors. Dr Mitchell is a clinical professor of medicine and medical oncology, and programme leader of gastrointestinal oncology at Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. She will replace Dr David Gandara who resigned from the board on January 19. PCR genetic testing specialist Response (Los Angeles, California) has developed three cancer diagnostics: ResponseDX:Lung, ResponseDX:Colon, and ResponseDX:Gastric, to help guide treatment decisions for patients with non-small cell lung cancer, colorectal cancer and gastric cancer, respectively.